Latest Breaking News On - Tial bush - Page 1 : comparemela.com

Centessa Pharmaceuticals plc (NASDAQ:CNTA) Given Consensus Rating of Moderate Buy by Brokerages

Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) has earned an average rating of “Moderate Buy” from the seven brokerages that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and five have issued a buy recommendation on […]

Tial bushAntoine yverGoldman sachs group incCentessa pharmaceuticalsSusquehanna international groupAnalyst recommendations for centessa pharmaceuticalsInsider activity at centessa pharmaceuticalsCentessa pharmaceuticals company profileJpmorgan chase coBarclays plcGoldman sachs groupRenaissance technologiesCentessa pharmaceuticals tradingNews ratings for centessa pharmaceuticals dailySecurities exchange commissionGet free report

Q3 2023 Earnings Estimate for Centessa Pharmaceuticals plc Issued By Leerink Partnrs (NASDAQ:CNTA)

Centessa Pharmaceuticals plc (NASDAQ:CNTA – Free Report) – Leerink Partnrs decreased their Q3 2023 EPS estimates for shares of Centessa Pharmaceuticals in a research note issued to investors on Tuesday, August 15th. Leerink Partnrs analyst D. Risinger now expects that the company will post earnings per share of ($0.45) for the quarter, down from their […]

Tial bushLeerink partnrsAntoine yverCentessa pharmaceuticalsCentessa pharmaceuticals stock performanceSusquehanna international groupJpmorgan chase coGoldman sachs groupNews ratings for centessa pharmaceuticals dailyGoldman sachs group incHedge funds weigh in on centessa pharmaceuticalsInsider transactions at centessa pharmaceuticalsRenaissance technologiesBarclays plcSecurities exchange commissionFree report

Centessa Pharmaceuticals plc to Post Q3 2023 Earnings of ($0 45) Per Share, Leerink Partnrs Forecasts (NASDAQ:CNTA)

Centessa Pharmaceuticals plc to Post Q3 2023 Earnings of ($0 45) Per Share, Leerink Partnrs Forecasts (NASDAQ:CNTA)
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Tial bushLeerink partnrsAntoine yverCentessa pharmaceuticalsGoldman sachs groupNews ratings for centessa pharmaceuticals dailyJpmorgan chase coCentessa pharmaceuticals stock downPrelude capital managementFree reportCentessa pharmaceuticalPharmaceuticals stock downCapital managementState equity partnersJane street groupGet free report

Centessa Pharmaceuticals (NASDAQ:CNTA) PT Raised to $5 00 at The Goldman Sachs Group

Centessa Pharmaceuticals (NASDAQ:CNTA) PT Raised to $5 00 at The Goldman Sachs Group
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Antoine yverTial bushCentessa pharmaceuticals price performanceInstitutional trading of centessa pharmaceuticalsCentessa pharmaceuticalsSecurities exchange commissionAnalyst recommendations for centessa pharmaceuticalsCentessa pharmaceuticals company profileGoldman sachs groupJpmorgan chase coBlackrock incBarclays plcNews ratings for centessa pharmaceuticals dailyGeode capital managementGet free reportExchange commission

Centessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Down 8 4%

Centessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Down 8 4%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Tial bushAntoine yverJpmorgan chase coInstitutional investors weigh in on centessa pharmaceuticalsNews ratings for centessa pharmaceuticals dailySecurities exchange commissionPrelude capital managementBarclays plcCentessa pharmaceuticalsSusquehanna international groupRenaissance technologiesCentessa pharmaceuticals stockGet free reportExchange commissionCapital managementInternational group